Kg. Danielsson et al., Comparison between oral and vaginal administration of misoprostol on uterine contractility, OBSTET GYN, 93(2), 1999, pp. 275-280
Objective: To compare the degree of absorption and the effect on uterine co
ntractility of the prostaglandin E-1 analogue misoprostol after vaginal and
oral administration.
Methods: Thirty women with a normal intrauterine pregnancy between 8 and 11
weeks' gestation who requested termination of pregnancy were given either
0.2 mg (orally n = 5; vaginally n = 6) or 0.4 mg (orally n = 10; vaginally
n = 9) of misoprostol. Intrauterine pressure was recorded using a Grass pol
ygraph connected to a pressure transducer 30 minutes before misoprostol was
given and for 4 hours thereafter. At the end of the recording, suction cur
ettage was performed. Blood samples were obtained at 0, 0.5, 1, 2, 4, and 6
hours for measurement of misoprostol, which was assayed by high-pressure l
iquid chromatography-mass spectrometry.
Results: In all patients, the first effect was an increase in uterine tonus
. After 0.4 mg of misoprostol administered orally, uterine tonus started to
increase after a mean (+/- standard deviation) time of 7.8 +/- 3.0 minutes
and reached its maximum after 25.5 +/- 5.0 minutes. The corresponding time
s after vaginal administration were 20.9 +/- 5.3 minutes and 46.3 +/- 20.7
minutes, respectively. The initial increase in tonus was also more pronounc
ed after oral than after vaginal administration. After vaginal administrati
on, all patients developed uterine contractions; the activity, measured in
Montevideo units, increased continuously during the observation period. Thi
s was not the case after oral administration. Plasma levels of misoprostol
were measured in 18 patients. The highest levels were found 30 minutes afte
r oral treatment and 1-2 hours after vaginal administration.
Conclusion: The long-lasting and continuously increasing uterine contractil
ity after vaginal administration can be explained only in part by a direct
effect of misoprostol. The longer period of elevated plasma levels of misop
rostol may also have initiated the prolonged events leading to increased ut
erine contractility. (Obstet Gynecol 1999;93:275-80. (C) 1999 by The Americ
an College of Obstetricians and Gynecologists.).